Nicholas Piramal

Nicholas Piramal to take over UK''s Rhodia

By Mumbai: | 18 Dec 2004

Nicholas Piramal finalises product in-licensing agreement with Ethypharm, France

By Mumbai: | 18 Aug 2004

Nicholas Piramal in research collaboration with National Institute of Immunology

By Mumbai: | 12 Aug 2004

Nicholas Piramal seals an in-licensing agreement with Genzyme Corporation for the Indian market

By Mumbai: | 11 Aug 2004

Nicholas Piramal, Indian Institute of Science to develop anti-fungal drugs

By Mumbai: | 31 Mar 2004

Maneesh Nerurkar joins Nicholas Piramal as head of Formulations Research

By Dr. Maneesh Nerurkar has | 31 Mar 2004

Nicholas Piramal expands its Clinical Research facility

By Mumbai: | 24 Mar 2004

World-renowned bioscientist, Dr. Saran Narang joins Nicholas Piramal Scientific Advisory Board

By Mumbai: | 04 Mar 2004

Nicholas Piramal Q3 growth up 76.1 per cent

By Mumbai: | 07 Feb 2004

Nicholas Piramal merges Canere Actives and Fine Chemicals Pvt. Ltd.

By Mumbai: | 07 Feb 2004

Nicholas Piramal, SPPL debt programmes reaffirmed A1+

By Mumbai: | 06 Jan 2004

Nicholas Piramal buys partner''s 50% stake in Sarabhai Piramal

By Mumbai: | 26 Dec 2003

Nicholas Piramal enters into alliance with Biogen Idec, USA

By Mumbai: | 02 Dec 2003

GlaxoSmithKline declares second interim dividend of 37%

By Our Corporate Bureau | 21 Dec 2002

Nicholas Piramal net profit at Rs 311 million

By Pradeep Rane | 19 Jul 2002

Nicholas Piramal to focus on mega brands

18 Jun 2002

NPIL ropes in McKinsey for total integration

27 May 2002

GlaxoSmithkline to launch new products

By Pradeep Rane | 12 Mar 2002

Nicholas Piramal''s new business strategy

04 Mar 2002

Pharma companies in talks with MIDC

By Praveen Chandran | 13 Dec 2001

Nicholas Piramal to focus on biotech

13 Nov 2001

Nicholas Piramal-Rhone merger over

By Nisha Das | 10 Oct 2001

Nicholas Piramal to launch drug for malaria

By Ananth Iyer | 19 Feb 2000

About osteoarthritis

21 Jan 2000

Piramal drug for osteoarthritis

By Ananth Iyer | 21 Jan 2000